Assure Receives Notice From Nasdaq That It Has Granted The Co An Extension To Regain Compliance With The Continued Listing Requirements For The Nasdaq Capital Market
Assure Receives Notice From Nasdaq That It Has Granted The Co An Extension To Regain Compliance With The Continued Listing Requirements For The Nasdaq Capital Market
Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today it received a written notice from the Nasdaq Listing Qualifications Panel (the "Hearings Panel") of The Nasdaq Stock Market LLC ("Nasdaq") that it has granted the Company an extension to regain compliance with the continued listing requirements for The Nasdaq Capital Market (the "Panel Decision"). The Hearings Panel granted the Company an extension until July 22, 2024, by which date the Company will be required to demonstrate compliance with all applicable initial listing requirements for the Nasdaq Capital Market in relation to its completion of its previously announced transaction with Danam Health Inc.
術中神經監測（“IONM”）和遠程神經病學服務提供商Assure Holdings Corp.（“公司” 或 “Assure”）（納斯達克股票代碼：IONM）今天宣佈，它收到了納斯達克股票市場有限責任公司（“納斯達克”）納斯達克上市資格小組（“聽證小組”）的書面通知，表示已批准公司延期，以恢復對納斯達克資本市場的持續上市要求的遵守（“小組決定”）。聽證會小組批准該公司將期限延長至2024年7月22日，屆時公司將被要求在完成先前宣佈的與達南健康公司的交易時證明遵守了納斯達克資本市場所有適用的初始上市要求。
譯文內容由第三人軟體翻譯。